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Abstract
Cystic pancreatic neoplasms are uncommon, but are being seen more frequently due to the widespread use of cross-
sectional imaging. In this article, we will address the clinical and imaging features of the more commonly seen
neoplasms. Points of differentiation between these neoplasms, the use of cyst fluid analysis and an approach to the
incidentally discovered cystic mass will be addressed.
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Introduction
Cystic pancreatic neoplasms are rare, accounting for
less than 1% of pancreatic neoplasms. The differential
diagnosis for a cystic pancreatic mass includes the
following:
• pseudocyst
• serous neoplasms cystadenoma/adenocarcinoma
• mucinous neoplasms
• solid pseudo-papillary epithelial neoplasm
• Von-Hippel Lindau disease
• cystic islet cell neoplasms
• cystic metastases
• lymphangioma
• giant cell neoplasm.
However, Sarr and his colleagues [1] have classified these
rare neoplasms into a more simplified and practical
working classification, which is as follows:
• serous cystic neoplasms
• mucinous cystic neoplasms
• intraductal papillary mucin-producing neoplasms
• other less common neoplasms.
The following discussion will be restricted to the more
common neoplasms.
Serous cystic neoplasms
Previously referred to as a microcystic neoplasm, this
is a benign neoplasm and is commonly seen in women,
usually in the fifth or sixth decades of life. The most
common type of serous neoplasm, the microlacunar
type, has a characteristic imaging appearance on CT
and MRI [2–4]. It is usually seen as a lobulated mass
with small cysts defined by septations and a central
scar (Figs 1 and 2). The central scar may have
areas of calcification, although this is uncommon. This
results in a honeycomb appearance with the central
calcifications producing a sunburst pattern. While this
appearance is almost pathognomonic for the diagnosis
of a serous cystic neoplasm, it is unfortunately not seen
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in all serous cystic neoplasms [2,3]. The cystic nature
of the mass and the septae is better appreciated on
ultrasonography. However, if the cysts are very small,
these neoplasms can appear echogenic and resemble
other solid pancreatic neoplasms. On angiography these
neoplasms can be hypervascular. Pathologically, the
neoplasm has a honeycomb appearance with the septae
and the central scar. Microscopically, the cysts are filled
with glycogen and the cystic spaces are lined with flat
epithelial cells. In view of the glycogen content within
the cysts, these neoplasms are also referred to as the
glycogen-rich neoplasms.
Figure 1 Contrast-enhanced CT shows a lobulated
multiseptate mass in the pancreatic head. The small
cystic spaces defined by the septae are typical for a
serous tumor.
Mucinous cystic neoplasm (MCT)
Also called macrocystic neoplasms, these neoplasms are
also seen most commonly in women in the fifth and sixth
decades of life. Approximately 80% of these tumors tend
to involve the body and tail of the pancreas. The mucinous
neoplasms have larger thick-walled cysts (Fig. 3). The
cysts are usually larger, greater than 2 cm in size,
and fewer in number than serous neoplasms. They can
be unilocular or multilocular in nature [4–8]. When the
neoplasm is unilocular it cannot be easily distinguished
from a pseudocyst. In mucinous neoplasms, thick-walled
cysts with nodularity and excrescences are noted on
pathology. The cysts are filled with thick mucinous
material and, on microscopy, are lined with goblet cells,
which produce mucin. Epithelium ranging from normal to
cellular atypia to frank adenocarcinoma may line the wall
of one cyst. For this reason, cyst wall biopsy is not helpful
in deciding whether or not the cyst is malignant. The
biologic behaviour of these neoplasms is dependent on
presence or absence of invasion. Non-invasive neoplasms,
when completely resected, have an excellent prognosis;
invasive neoplasms have a poor prognosis, similar to that
seen in ductal adenocarcinoma.
Figure 2 Single-shot fast spin-echo coronal MR
image demonstrates a lobulated multiseptate mass
in the uncinate process. The small cystic spaces and
septae, both of which are characteristic of a serous
tumor, are well demonstrated. Arrow demonstrates
the duct of Wirsung (WD). [Courtesy of Dr Mark R
Paley MD, Hammersmith Hospital, London, UK].
Figure 3 Contrast-enhanced CT shows a cystic mass
in the mid-body of the pancreas. The mass has areas
of cystic degeneration but has solid nodules. The
location and appearance are suggestive of mucinous
neoplasm, which this proved to be on subsequent
surgical resection.
Imaging differences between serous
and mucinous cystic neoplasms
Johnson et al. reported a classification scheme which is of
some use in distinguishing between serous and mucinous
neoplasms [2]. Useful criteria include the number of cysts
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Figure 4 Contrast-enhanced CT demonstrates marked pancreatic duct dilatation throughout the main
pancreatic duct, with cystic spaces in the uncinate process. On endoscopy a dilated bulging papilla with
abundant mucin exuding from it was found. These findings are characteristic of an intraductal mucin-
producing tumor of the main duct type.
(less than six in MCT neoplasm, greater than six in serous
cystic neoplasm) and size of the majority of cysts (greater
than 2 cm in MCT neoplasm and less than 2 cm in serous
cystic neoplasm). Using these criteria, an accuracy rate of
70–80% was achieved in distinguishing the benign serous
from the malignant mucinous neoplasms.
However, a more recent study of 100 cystic neoplasms
(excluding pseudocysts) by Procacci et al. found that
accurate characterisation was possible in only 60% of
neoplasms. In general, serous neoplasms were more
accurately diagnosed than mucinous neoplasms. 15–
20% of neoplasms were incorrectly diagnosed due to
the overlap of imaging features [9]. Curry et al. also
reported low accuracy rates when readers were asked
to classify cystic neoplasms into serous or mucinous
categories [10].
Intraductal papillary mucinous or
mucin-producing neoplasm (IPMT)
Considered to be a relatively new entity, IPMT represents
a spectrum of a neoplastic process, which has been previ-
ously referred to by a variety of terminology. Controversy
remains as to the exact nature of the neoplasm, its biology
and also its management and treatment. However, there
are some distinct cross-sectional imaging characteristics
that correlate well with the documented endoscopic
retrograde cholangiopancreatography (ERCP) findings.
These include a markedly dilated pancreatic duct,
excessive mucin secretion and bulging papilla.
Depending on whether the main pancreatic duct or
a side branch is involved, these neoplasms have been
divided into:
• main duct type
• side branch or branch duct type.
The imaging appearances of the two types can vary
[11–17]
.
Main duct type
The main duct type of this neoplasm can involve either
a segment of the main duct or the duct diffusely. The
pancreatic duct is dilated and is filled with mucin. Filling
defects due to mucin deposits or neoplasm can be seen
within the dilated main pancreatic duct as well as within
large tubular cystic spaces (Fig. 4). Thin-section CT and
magnetic resonance cholangiopancreatography (MRCP)
can demonstrate the communication of these dilated
cystic spaces with the main pancreatic duct [14]. ERCP has
been the gold standard for making this diagnosis, when
it demonstrates a bulging papilla with an outpouring
of large amounts of mucinous material from it. As the
imaging findings often resemble that of pancreatitis, these
patients are often misdiagnosed and treated as having
chronic pancreatitis. On ERCP and MRCP, a dilated main
pancreatic duct with beading of the side branches can be
seen (Fig. 5(a)) and at times filling defects within these
dilated ducts due to mucin or tumor nodules can be seen
(Fig. 5(b)) [15,16].
Side branch type
The side branch or branch duct type of this neoplasm is
usually confined to the head and uncinate process. On CT
and MR a cystic mass is seen which can resemble serous
and mucinous neoplasms (Fig. 6). On ERCP and MRCP,
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Figure 5 ERCP can demonstrate features which resemble those of pancreatitis, such as a dilated main duct
with beaded appearance to the side branches (a), or demonstrate filling defects in these dilated ducts which
may be due to mucin or tumor nodules (arrow) (b).
a characteristic appearance of cystic masses is seen,
resembling a ‘cluster of grapes’, which communicates
with the pancreatic duct [11–17].
The main duct type of IPMT is thought to be more
malignant and requires surgical treatment in the form of a
total or subtotal pancreatectomy. In contrast, side branch
neoplasms are thought to be less aggressive and can be
either observed or resected with a Whipple procedure.
The prognosis for the side branch type neoplasms is
excellent in contrast to that for the main duct type,
which if invasive can be similar to that for ductal
adenocarcinoma.
Solid pseudo-papillary epithelial
neoplasms
Solid and cystic papillary epithelial neoplasms are
unusual neoplasms commonly seen in women in the 20–
40-year age range. These neoplasms have an excellent
prognosis and are considered a low-grade malignant
neoplasm. They can be entirely cystic or solid but
can have both solid and cystic components (Fig. 7).
Hemorrhage and fluid levels are reportedly common.
These neoplasms can metastasise to the liver and upper
abdominal nodes [18,19]. As they are considered to be
of low malignant potential and have a good prognosis,
neoplasm resection is at times undertaken even in the
presence of metastatic disease.
Figure 6 Contrast-enhanced CT demonstrates a
cystic mass in the uncinate process of the pancreas.
This on surgery proved to be an intraductal mucin-
producing tumor of the side branch or branch duct
type. These are usually confined to the uncinate
process but can be only readily diagnosed on ERCP
(Fig. 7). On imaging, the appearances can resemble
that of a serous or mucinous tumor.
Aspiration biopsy and cyst fluid
analysis of cystic neoplasms
There are data suggesting that differentiation between
the benign and malignant cystic neoplasms may be
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Figure 7 Contrast-enhanced CT (a) in a 25-year-old woman demonstrates a large multilobulated cystic mass
with soft tissue nodules and excrescences involving the body and tail of the pancreas. This imaging appearance
is re-demonstrated on a moderately T2-weighted MR image (b). On surgery this proved to be a solid pseudo-
papillary neoplasm.
achieved with high sensitivity, based on analysis of the
cyst fluid for carcino-embryonic antigen (CEA) and other
neoplastic markers such as CA-129 as well as amylase
levels [20,21]. The CEA and other neoplasm marker levels
are high in the malignant cystic neoplasms and low in the
pseudocysts and in the serous cystic neoplasms.
Histological analysis of fine-needle aspiration (FNA)
biopsy is fraught with problems, as the lining epithelium
of the serous and cystic neoplasms can be incomplete
and/or heterogeneous; thus a biopsy at one site may not
be a true representation of the neoplasm type.
Incidental ‘cystic lesions’ in
asymptomatic patients
Due to the widespread use of imaging, small 1–
3 cm cystic masses in the pancreas are being more
commonly seen in asymptomatic individuals. As true
epithelial cysts of the pancreas are extremely rare,
these are a diagnostic problem. Some believe that they
may represent side duct intraductal neoplasms, and
recommend follow-up to ensure stability. An ERCP or
MRCP may also prove the true nature of the lesion by
demonstrating a communication with the pancreatic duct,
which is characteristic of an IPMT. If these lesions are
being managed conservatively and followed with serial
imaging, surgical resection should be performed if there
is any change in size or internal features [22].
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